Homeostatic control of synaptic activity by endogenous adenosine is mediated by adenosine kinase

Cerebral Cortex

Volumn 24, Issue 1, 2014, Pages 67-80

  Diógenes, Maria José ^a,b   Neves Tomé, Raquel ^a,b   Fucile, Sergio ^c,d   Martinello, Katiuscia ^d   Scianni, Maria ^c   Theofilas, Panos ^f   Lopatář, Jan ^e   Ribeiro, Joaquim A ^a,b   Maggi, Laura ^c   Frenguelli, Bruno G ^e   Limatola, Cristina ^c,d   Boison, Detlev ^f   Sebastião, Ana M ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d IRCCS NEUROMED   (Italy)

^e UNIVERSITY OF WARWICK   (United Kingdom)

^f LEGACY RESEARCH   (United States)

Author keywords

Adenosine; Brain derived neurotrophic factor; GABA; Homeostasis; Transgenic mice

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE KINASE; BRAIN DERIVED NEUROTROPHIC FACTOR; ADENOSINE A2A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; ENZYMIC BIOSENSOR; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HOMEOSTASIS; MICROELECTRODE; MOUSE; NERVE CELL PLASTICITY; NERVE CONDUCTION; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION; ADULT; ANIMAL CELL; ANIMAL TISSUE; BIOSENSOR; NERVE CELL EXCITABILITY; NEUROMODULATION;

ADENOSINE; BRAIN-DERIVED NEUROTROPHIC FACTOR; GABA; HOMEOSTASIS; TRANSGENIC MICE;

ADENOSINE; ADENOSINE KINASE; ANIMALS; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CA1 REGION, HIPPOCAMPAL; CA3 REGION, HIPPOCAMPAL; ELECTROPHYSIOLOGICAL PROCESSES; EXCITATORY POSTSYNAPTIC POTENTIALS; EXTRACELLULAR SPACE; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOSSY FIBERS, HIPPOCAMPAL; NEURONAL PLASTICITY; PATCH-CLAMP TECHNIQUES; PURINES; RECEPTOR, ADENOSINE A2A; RECEPTORS, GABA-A; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84890454797     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhs284     Document Type: Article

References (60)

1. Anderson WW, Collingridge GL. 2001. The LTP Program: A data acquisition program for on-line analysis of long-Term potentiation and other synaptic events. J Neurosci Methods. 108:71-83
2. Aronica E, Zurolo E, Iyer A, de Groot M, Anink J, Carbonell C, van Vliet EA, Baayen JC, Boison D, Gorter JA. 2011. Upregulation of aDenosine kinase in astrocytes in experimental and human temporal lobe epilepsy. Epilepsia. 52:1645-1655
3. Assaife-Lopes N, Sousa VC, Pereira DB, Ribeiro JA, Chao MV, Sebastião AM. 2010. Activation of aDenosine A2A receptors induces TrkB translocation and increases BDNF-mediated phospho-TrkB localization in lipid rafts: Implications for neuromodulation. J Neurosci. 30:8468-8480
4. Boison D. 2009. ADenosine augmentation therapies (AATs) for epilepsy: Prospect of cell and gene therapies. Epilepsy Res. 85:131-141
5. Boison D, Chen JF, Fredholm BB. 2010. ADenosine signaling and function in glial cells. Cell Death Differ. 17:1071-1082
6. Boison D, Masino SA, Geiger JD. 2011. Homeostatic bioenergetic network regulation-A novel concept to avoid pharmacoresistance in epilepsy. Expert Opin Drug Discov. 6:713-724
7. Boison D, Singer P, Shen HY, Feldon J, Yee BK. 2012. ADenosine hypothesis of schizophrenia-opportunities for pharmacotherapy. Neuropharmacology. 62:1527-1543
8. Boison D, Stewart KA. 2009. Therapeutic epilepsy research: From pharmacological rationale to focal aDenosine augmentation. Biochem Pharmacol. 78:1428-1437
9. Chitwood RA, Jaffe DB. 1998. Calcium-DepenDent spike-frequency accommodation in hippocampal CA3 nonpyramidal neurons. J Neurophysiol. 80:983-988
10. Cunha RA, Johansson B, van der Ploeg I, Sebastião AM, Ribeiro JA, Fredholm BB. 1994. EviDence for functionally important aDenosine A2a receptors in the rat hippocampus. Brain Res. 649:208-216
11. de Groot M, Iyer A, Zurolo E, Anink J, Heimans JJ, Boison D, Reijneveld CJ, Aronica E. 2012. Overexpression of ADK in human astrocytic tumors and peritumoral tissue is related to tumor-Associated epilepsy. Epilepsia. 53:58-66
12. de Mendonça A, Sebastião AM, Ribeiro JA. 1995. Inhibition of NMDA receptor-mediated currents in isolated rat hippocampal neurones by aDenosine A1 receptor activation. Neuroreport. 6:1097-1100
13. Diógenes MJ, Assaife-Lopes N, Pinto-Duarte A, Ribeiro JA, Sebastião AM. 2007. Influence of age on BDNF modulation of hippocampal synaptic transmission: Interplay with aDenosine A2A receptors. Hippocampus. 17:577-585
14. Diógenes MJ, Costenla AR, Lopes LV, Jerónimo-Santos A, Sousa VC, Fontinha BM, Ribeiro JA, Sebastião AM. 2011. Enhancement of LTP in aged rats is depenDent on endogenous BDNF. Neuropsychopharmacology. 36:1823-1836
15. Diógenes MJ, Fernandes CC, Sebastião AM, Ribeiro JA. 2004. Activation of aDenosine A2A receptor facilitates brain-Derived neurotrophic factor modulation of synaptic transmission in hippocampal slices. J Neurosci. 24:2905-2913
16. Dolphin AC, Prestwich SA. 1985. Pertussis toxin reverses aDenosine inhibition of neuronal glutamate release. Nature. 316:148-150
17. Dunwiddie TV. 1980. Endogenously released aDenosine regulates excitability in the in vitro hippocampus. Epilepsia. 21:541-548
18. Etherington LA, Frenguelli BG. 2004. Endogenous aDenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-DepenDent manner. Eur J Neurosci. 19:2539-2550
19. Etherington LA, Patterson GE, Meechan L, Boison D, Irving AJ, Dale N, Frenguelli BG. 2009. Astrocytic aDenosine kinase regulates basal synaptic aDenosine levels and seizure activity but not activity-DepenDent aDenosine release in the hippocampus. Neuropharmacology. 56:429-437
20. Fedele DE, Gouder N, Guttinger M, Gabernet L, Scheurer L, Rulicke T, Crestani F, Boison D. 2005. Astrogliosis in epilepsy leads to overexpression of aDenosine kinase, resulting in seizure aggravation. Brain. 128:2383-2395
21. Fernandes CC, Pinto-Duarte A, Ribeiro JA, Sebastião AM. 2008. Postsynaptic action of brain-Derived neurotrophic factor attenuates alpha7 nicotinic acetylcholine receptor-mediated responses in hippocampal interneurons. J Neurosci. 28:5611-5618
22. Ferrero ME. 2011. Purinoceptors in inflammation: Potential as anti-inflammatory therapeutic targets. Front Biosci. 17:2172-2186
23. Fontinha BM, Diógenes MJ, Ribeiro JA, Sebastião AM. 2008. Enhancement of long-Term potentiation by brain-Derived neurotrophic factor requires aDenosine A2A receptor activation by endogenous aDenosine. Neuropharmacology. 54:924-933
24. Frenguelli BG, Llaudet E, Dale N. 2003. High-resolution real-Time recording with microelectrode biosensors reveals novel aspects of aDenosine release during hypoxia in rat hippocampal slices. J Neurochem. 86:1506-1515
25. Frenguelli BG, Wigmore G, Llaudet E, Dale N. 2007. Temporal and mechanistic dissociation of ATP and aDenosine release during ischaemia in the mammalian hippocampus. J Neurochem. 101:1400-1413
26. Gouder N, Scheurer L, Fritschy J-M, Boison D. 2004. Overexpression of aDenosine kinase in epileptic hippocampus contributes to epileptogenesis. J Neurosci. 24:692-701
27. Kamiya H, Shinozaki H, Yamamoto C. 1996. Activation of metabotropic glutamate receptor type 2/3 suppresses transmission at rat hippocampal mossy fibre synapses. J Physiol. 493(Pt 2):447-455
28. Kukley M, Schwan M, Fredholm BB, Dietrich D. 2005. The role of extracellular aDenosine in regulating mossy fiber synaptic plasticity. J Neurosci. 25:2832-2837
29. Lacaille JC, Mueller AL, Kunkel DD, Schwartzkroin PA. 1987. Local circuit interactions between oriens/alveus interneurons and CA1 pyramidal cells in hippocampal slices: Electrophysiology and morphology. J Neurosci. 7:1979-1993
30. Li T, Lan JQ, Boison D. 2008. Uncoupling of astrogliosis from epileptogenesis in aDenosine kinase (ADK) transgenic mice? Neuron Glia Biol. 4:91-99
31. Li T, Quan Lan J, Fredholm BB, Simon RP, Boison D. 2007. ADenosine dysfunction in astrogliosis: Cause for seizure generation. Neuron Glia Biol. 3:353-366
32. Li T, Ren G, Lusardi T, Wilz A, Lan JQ, Iwasato T, Itohara S, Simon RP, Boison D. 2008. ADenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J Clin Invest. 118:571-582
33. Lopatar J, Dale N, Frenguelli BG. 2011. Minor contribution of ATP P2 receptors to electrically-evoked electrographic seizure activity in hippocampal slices: EviDence from purine biosensors and P2 receptor agonists and antagonists. Neuropharmacology. 61:25-34
34. Lopes LV, Sebastião AM, Ribeiro JA. 2011. ADenosine and related drugs in brain diseases: Present and future in clinical trials. Curr Top Med Chem. 11:1087-1101
35. Lovatt D, Xu Q, Liu W, Takano T, Smith NA, Schnermann J, Tieu K, Nedergaard M. 2012. Neuronal aDenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity. Proc Natl Acad Sci USA. 109:6265-6270
36. Marchi M, Raiteri L, Risso F, Vallarino A, Bonfanti A, Monopoli A, Ongini E, Raiteri M. 2002. Effects of aDenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes. Br J Pharmacol. 136:434-440
37. Masino SA, Kawamura M Jr, Ruskin DN, Geiger JD, Boison D. 2012. Purines and neuronal excitability: Links to the ketogenic diet. Epilepsy Res. 100:229-238
38. Masino SA, Li T, Theofilas P, Sandau US, Ruskin DN, Fredholm BB, Geiger JD, Aronica E, Boison D. 2011. A ketogenic diet suppresses seizures in mice through aDenosine A1 receptors. J Clin Inv. 121:2679-2683
39. Moore KA, Nicoll RA, Schmitz D. 2003. ADenosine gates synaptic plasticity at hippocampal mossy fiber synapses. Proc Natl Acad Sci USA. 100:14397-14402
40. Paradiso B, Zucchini S, Su T, Bovolenta R, Berto E, Marconi P, Marzola A, Navarro Mora G, Fabene PF, Simonato M. 2011. Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus. Epilepsia. 52:572-578
41. Pignataro G, Maysami S, Studer FE, Wilz A, Simon RP, Boison D. 2008. Downregulation of hippocampal aDenosine kinase after focal ischemia as potential endogenous neuroprotective mechanism. J Cereb Blood Flow Metab. 28:17-23
42. Pignataro G, Simon RP, Boison D. 2007. Transgenic overexpression of aDenosine kinase aggravates cell death in ischemia. J Cereb Blood Flow Metab. 27:1-5
43. Pousinha PA, Diógenes MJ, Ribeiro JA, Sebastião AM. 2006. Triggering of BDNF facilitatory action on neuromuscular transmission by aDenosine A2A receptors. Neurosci Lett. 404:143-147
44. Ragozzino D, Palma E, Di Angelantonio S, Amici M, Mascia A, Arcella A, Giangaspero F, Cantore G, Di Gennaro G, Manfredi M et al. 2005. Rundown of GABA type A receptors is a dysfunction associated with human drug-resistant mesial temporal lobe epilepsy. Proc Natl Acad Sci USA. 102:15219-15223
45. Rex CS, Kramar EA, Colgin LL, Lin B, Gall CM, Lynch G. 2005. Longterm potentiation is impaired in middle-Aged rats: Regional specificity and reversal by aDenosine receptor antagonists. J Neurosci. 25:5956-5966
46. Roseti C, Martinello K, Fucile S, Piccari V, Mascia A, Di Gennaro G, Quarato PP, Manfredi M, Esposito V, Cantore G et al. 2008. ADenosine receptor antagonists alter the stability of human epileptic GABAA receptors. Proc Natl Acad Sci USA. 105:15118-15123
47. Roseti C, Palma E, Martinello K, Fucile S, Morace R, Esposito V, Cantore G, Arcella A, Giangaspero F, Aronica E et al. 2009. Blockage of A2A and A3 aDenosine receptors decreases the desensitization of human GABA(A) receptors microtransplanted to Xenopus oocytes. Proc Natl Acad Sci USA. 106:15927-15931
48. Sebastião AM. 2010. ADenosine and epilepsy-Thinking beyond A(1) receptors. Purinergic Signal. 6:1-2
49. Sebastião AM, Assaife-Lopes N, Diógenes MJ, Vaz SH, Ribeiro JA. 2011. Modulation of brain-Derived neurotrophic factor (BDNF) actions in the nervous system by aDenosine A(2A) receptors and the role of lipid rafts. Biochim Biophys Acta. 1808:1340-1349
50. Sebastião AM, Ribeiro JA. 1992. EviDence for the presence of excitatory A2 aDenosine receptors in the rat hippocampus. Neurosci Lett. 138:41-44
51. Sebastião AM, Ribeiro JA. 2009. Tuning and fine-Tuning of synapses with aDenosine. Curr Neuropharmacol. 7:180-194
52. Sebastião AM, Stone TW, Ribeiro JA. 1990. The inhibitory aDenosine receptor at the neuromuscular junction and hippocampus of the rat: Antagonism by 1,3,8-substituted xanthines. Br J Pharmacol. 101:453-459
53. Shen HY, Lusardi TA, Williams-Karnesky RL, Lan JQ, Poulsen DJ, Boison D. 2011. ADenosine kinase determines the degree of brain injury after ischemic stroke in mice. J Cereb Blood Flow Metab. 31:1648-1659
54. Shen HY, Singer P, Lytle N, Wei CJ, Lan JQ, Williams-Karnesky RL, Chen JF, Yee BK, Boison D. 2012. ADenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia. J Clin Invest. 122:2567-2577
55. Simonato M, Tongiorgi E, Kokaia M. 2006. Angels and demons: Neurotrophic factors and epilepsy. Trends Pharmacol Sci. 27:631-638
56. Studer FE, Fedele DE, Marowsky A, Schwerdel C, Wernli K, Vogt K, Fritschy JM, Boison D. 2006. Shift of aDenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. Neuroscience. 142: 125-137
57. Tebano MT, Martire A, Potenza RL, Gro C, Pepponi R, Armida M, Domenici MR, Schwarzschild MA, Chen JF, Popoli P. 2008. ADenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus. J Neurochem. 104:279-286
58. Wilz A, Pritchard EM, Li T, Lan JQ, Kaplan DL, Boison D. 2008. Silk polymer-based aDenosine release: Therapeutic potential for epilepsy. Biomaterials. 29:3609-3616
59. Yee BK, Singer P, Chen JF, Feldon J, Boison D. 2007. Transgenic overexpression of aDenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs. Eur J Neurosci. 26:3237-3252
60. zur NedDen S, Hawley S, Pentland N, Hardie DG, Doney AS, Frenguelli BG. 2011. Intracellular ATP influences synaptic plasticity in area CA1 of rat hippocampus via metabolism to aDenosine and activity-DepenDent activation of aDenosine A1 receptors. J Neurosci. 31:6221-6234